Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

Clinical trial NCT06597513 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06597513
Sponsor: Zhou Chengzhi
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer

Start date: 2024-12-01
Primary completion: 2025-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.